This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing Vicarious Surgical's upcoming robot and competition from incumbents like Intuitive Surgical

Ticker(s): RBOT, RBOT-WT, ISRG

Who's the expert?

Ideally, we could discuss with one or more surgeons who have performed abdominal procedures or others familiar with medical hardware adoption.

Interview Questions
Q1.

Vicarious Surgical claims its robot has more degrees of freedom within the abdominal wall. It also has only a 1.5 cm port of entry. How much benefit do these factors have as compared to incumbent products such as those from Intuitive Surgical?

Added By: saminnovate
Q2.

Vicarious Surgical plans to submit a Denovo application to the FDA by end of 2024. How realistic is this in your view?

Added By: saminnovate
Q3.

Vicarious Surgical says only 3-4% of surgical procedures that could benefit from surgical robots currently use them. What are some of the challenges around surgical robot adoption in institutions?

Added By: saminnovate
Q4.

Would you expect surgical adoption to grow significantly in the next few years? Why or why not?

Added By: saminnovate
Q5.

Vicarious Surgical investors include Bill Gates, Vinod Khosla, Jerry Yang, and other well known tech investors. Do you think these investors make the technology more or less likely to succeed commercially?

Added By: saminnovate
Q6.

Vicarious Surgical was started in 2014, about 10 years after Intuitive Surgical. What opportunities and what challenges do you see as a newer entrant into surgical robotics?

Added By: saminnovate

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.